ADHD Predominantly Inattentive Type
Understanding ADHD Predominantly Inattentive Type (formerly known as ADD or Attention Deficit Disorder)? This resource provides information on diagnosis criteria, clinical documentation best practices for healthcare professionals, and relevant medical coding (ICD-10) for Attention Deficit Disorder Inattentive Type. Learn about symptoms, treatment options, and resources for managing inattention in patients with this subtype of ADHD.
Neurodevelopmental disorder marked by difficulty focusing, distractibility, and forgetfulness.
Inattention, poor organization, difficulty sustaining tasks, careless mistakes, appearing not to listen.
Primary care, psychiatry, psychology, school counseling.
ICD-10 Code Families
Complete code families applicable to F90.0
When to use each related code
| Description | When to use |
|---|---|
| Inattention, distractibility, disorganization without hyperactivity. | Primary inattention, difficulty focusing, forgetfulness, poor organization, but not hyperactive or impulsive. |
| Hyperactivity, impulsivity, restlessness with or without inattention. | Predominantly hyperactive-impulsive symptoms like fidgeting, interrupting, excessive talking. May or may not have inattention. |
| Combined inattention, hyperactivity, and impulsivity. | Both inattention and hyperactive-impulsive symptoms are significant and impair functioning. Most common ADHD presentation. |
Best-practice checklist
- ✓ADHD Inattentive Type DSM-5 criteria documented
- ✓Impairment in two settings (e.g., home, school)
- ✓Symptom onset before age 12 documented
- ✓Rule out other medical or psychiatric causes
- ✓ICD-10 code F90.0 clearly documented
Common pitfalls to avoid
Inaccurate coding if ADHD diagnosis is applied outside typical age range, impacting reimbursement and quality metrics.
Incorrectly coding co-existing conditions like anxiety or learning disabilities with ADHD, leading to inflated resource use.
Using unspecified ADHD codes when a more specific subtype (inattentive, hyperactive, combined) is documented, impacting data accuracy.
Best-practice tips
- 01ICD-10 F90.0, minimize distractions, structured routines.
- 02CPT 96101, clear instructions, frequent breaks, optimize learning.
- 03DSM-5 314.00, behavior therapy, mindfulness training, improve focus.
- 04Document symptom frequency/severity for accurate ADHD coding.
- 05Medication management, parent/teacher training, ensure compliance.
Step-by-step checklist
- 1
Verify inattention symptoms: difficulty focusing, forgetfulness (ICD-10 F90.0)
- 2
Rule out other causes: anxiety, depression, learning disabilities, sleep disorders
- 3
Assess functional impairment: academic, social, occupational impact documented
- 4
Age of onset before 12: confirm symptom presence prior to age 12 (DSM-5 criteria)
- 5
Symptom duration: persistent inattention for at least 6 months
Ready-to-paste narrative
Patient presents with symptoms consistent with ADHD Predominantly Inattentive Type, also known as Attention Deficit Disorder or ADD. Clinical presentation includes significant difficulties with sustained attention, organization, and task completion. The patient reports frequent forgetfulness, difficulty following instructions, and a tendency to lose focus easily. These symptoms are impacting academic performance, occupational functioning, and interpersonal relationships. The patient denies hyperactivity or impulsivity. Diagnostic criteria for ADHD Inattentive Presentation, as outlined in the DSM-5, appear to be met. Differential diagnoses considered include anxiety disorders, depression, learning disabilities, and sleep disorders. Assessment included a clinical interview, review of collateral information, and standardized rating scales for inattention symptoms. Treatment plan includes psychoeducation regarding ADHD Inattentive type, initiation of cognitive behavioral therapy (CBT) to address executive dysfunction and improve organizational skills, and exploration of potential medication management strategies. Patient education materials on ADHD management and treatment options were provided. Follow-up appointment scheduled to monitor treatment progress and assess response to interventions. ICD-10 code F90.0 will be used for medical billing and coding purposes. Continued monitoring and adjustment of the treatment plan will be based on the patient's ongoing symptom presentation and response to interventions.
Common questions and answers
How can I differentiate between ADHD Predominantly Inattentive Type and other presentations of ADHD in my adult patients, considering comorbid conditions?+
Differentiating ADHD Predominantly Inattentive Type (formerly known as ADD) from other ADHD presentations like the Hyperactive-Impulsive or Combined Type in adults requires careful assessment, especially with the presence of comorbid conditions like anxiety or depression, which can mimic or mask ADHD symptoms. Focus on identifying the core inattentive symptoms, such as difficulty sustaining attention, disorganization, forgetfulness, and distractibility, while noting the relative absence or lesser severity of hyperactive-impulsive symptoms like fidgeting, restlessness, and impulsivity. Comprehensive diagnostic interviews, rating scales (e.g., the Conners' Adult ADHD Rating Scales, the Adult ADHD Self-Report Scale), and a thorough history, including childhood behavior patterns, are crucial. Consider the impact of comorbid conditions on symptom presentation; for example, anxiety can exacerbate inattention. A differential diagnosis process should rule out other conditions like depression, anxiety disorders, learning disabilities, and sleep disorders. Explore how integrating validated assessment tools can enhance your diagnostic accuracy. Consider implementing structured interviews and rating scales for a more systematic evaluation of adult ADHD presentations. Learn more about the specific diagnostic criteria outlined in the DSM-5-TR for each ADHD presentation to aid in accurate diagnosis.
What are the best evidence-based non-pharmacological interventions for managing ADHD Predominantly Inattentive Type in adults, specifically for improving executive function deficits?+
Several evidence-based non-pharmacological interventions can significantly improve executive function deficits in adults with ADHD Predominantly Inattentive Type. Cognitive Behavioral Therapy (CBT) tailored to ADHD addresses challenges with organization, time management, and emotional regulation. Specifically, techniques like cognitive restructuring, behavioral activation, and goal setting can improve focus, planning, and impulse control. Additionally, specialized organizational skills training and time management interventions can directly target common executive function weaknesses seen in this presentation. Mindfulness-based interventions like meditation and yoga can also enhance attention and self-regulation. Furthermore, neurofeedback and working memory training programs show promise in improving cognitive performance. Explore how incorporating these interventions into treatment plans can enhance outcomes for adults with ADHD Predominantly Inattentive Type. Consider implementing a multimodal approach combining pharmacological and non-pharmacological strategies for optimal management of executive function deficits.
When is pharmacotherapy indicated for ADHD Predominantly Inattentive Type in adults, and what are the key considerations for choosing the appropriate medication and managing potential side effects?+
Pharmacotherapy is often indicated for adults with ADHD Predominantly Inattentive Type when symptoms significantly impair daily functioning, including academic or occupational performance, relationships, and overall quality of life. Stimulant medications, such as methylphenidate and amphetamines, are considered first-line treatment, effectively improving attention, focus, and executive functions. Non-stimulant options, like atomoxetine and guanfacine, are also available and may be preferable for individuals with certain comorbid conditions or contraindications to stimulants. The choice of medication depends on individual patient factors, including medical history, comorbid conditions, potential drug interactions, and patient preference. Careful monitoring of side effects, such as appetite changes, sleep disturbances, and cardiovascular effects, is essential. Titration to an optimal dose while minimizing adverse effects is crucial for maximizing treatment efficacy. Consider implementing a shared decision-making approach with patients, discussing the risks and benefits of each medication option. Learn more about the specific mechanisms of action and potential side effect profiles of different ADHD medications to inform treatment decisions and provide patient education. Explore how personalized medicine approaches can be used to optimize medication selection and dosage for individual needs.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.